16. Jung S.H., Yoon S.M., Park S.H., Choi I.S., Kim J.K., Choi E.K., Ahn S.D., Lee S.W., Song S.Y., Kim J.H. A treatment planning study on glioblastoma with different techniques using boron neutron capture therapy, 3-dimensional conformal radiotherapy, and intensity modulated radiotherapy. Appl. Radiat. Isot. 2009. Vol. 67. No. 7-8. P. 1180-1184. DOI: 10.1016/j.apradiso.2009.02.005.
17. Lin K.H., Chen Y.W., Lee R.C., Wang L.W., Chou F.I., Chang C.W., Yen S.H, Huang W.S. Nuclear theranostics in Taiwan. Nucl. Med. Mol. Imaging. 2019. Vol. 53. No. 2. P. 86-91. DOI: 10.1007/s13139-019-00576-z.
18. Lan T.L., Chou F.I., Huang W.S., Lin K.H., Lee Y.Y., Pan P.S., Kuo Y.C., Hsu S.M., Chang F.C., Liang M.L., Lee J.C., Lin S.C., Liu Y.M, Chao Y., Chen Y.W. Overt tumor regression after salvage boron neutron capture therapy (BNCT) for a recurrent glioblastoma patient. Ther. Radiol. Oncol. 2018. Vol. 2. P. 48. DOI: 10.21037/tro.2018.10.09/.
19. Yoe S.D., Teng Y.C., Liu Y.H., Lin T.Y., Chen Y.W., Wu Y.H., Lee J.C., Lin K.H., Huang W.S. Evaluation of multi-field technique applied to boron neutron capture therapy for brain tumors. Abstract Book of the 18th International Congress on Neutron Capture Therapy. Taipai, Taiwan, October 28 - November 2, 2018. P. 148-149.
20. Lan T.L., Chou F.I., Tanaka H., Kuo Y.C., Lin K.H., Pan P.S., Hsu S.M., Lee J.C., Huang W.S., Liu Y.M., Chen Y.W. Salvage Boron Neutron Capture Therapy (BNCT), treatment experiences of recurrent malignant brain tumors in Taiwan. Abstract Book of the 18th International Congress on Neutron Capture Therapy. Taipai, Taiwan, October 28 - November 2, 2018. P. 36-37.
21. Таскаев С.Ю., Каныгин В.В. Бор-нейтронозахватная терапия. Новосибирск: Издательство СО РАН, 2016. 216 с.
22. Bayanov B., Burdakov V., Ivanov A., Kasatov D., Kolesnikov J., Koshkarev A., Kuznetsov A., Makarov A., Ostreinov Yu., Sokolova E., Sorokin I., Sycheva T., Taskaev S., Shchudlo I., Kanygin V., Kichigin A., Zdanova M., Yarullina A., Frolov S., Lezhnin S., Byvaltsey V., Gavrilova Y., Gromilov S., Muhamadiyarov R., Zaidi L. Readiness for boron neutron capture therapy. In: 2015 International Conference on Biomedical Engineering and Computational Technologies (SIBIRCON). Novosibirsk, 2015. P. 27-32. DOI: 10.1109/SIBIRCON.2015.7361844.
23. Taskaev S.Y., Kanygin V.V., Byvaltsev V.A., Zaboronok A.A., Volkova O.Yu., Mechetina L.V., Taranin A.V., Kichigin A.I., Iarullina A.I., Eliseenko I.A., Nakai K., Sato E., Yamamoto T., Ishikawa E., Matsumura A. Opportunities for using an accelerator-based epithermal neutron source for boron neutron capture therapy. Biomed Eng. 2018. Vol. 52. No. 2. P. 73-76. DOI: 10.1007/s10527-018-9785-0.
24. Aleynik V., Bashkirtsev A., Kanygin V., Kasatov D., Kuznetsov A., Makarov A., Schudlo I., Sorokin I., Taskaev S., Tiunov M. Current progress and future prospects of the VITA based neutron source. Appl. Radiat. Isot. 2014. Vol. 88. P. 177-179. DOI:10.1016/j.apradiso.2013.11.132.
25. Каныгин В.В., Завьялов Е.Л., Симонович А.Е., Касатова А.И., Кичигин А.И., Разумов И.А., Таскаев С.Ю. Бор-нейтронозахватная терапия глиобластомы человека на моделях опухоли in vivo // Современные проблемы науки и образования. 2019. № 1. [Электронный ресурс]. URL: http://www.science-education.ru/ru/article/view?id=28480 (дата обращения: 15.05.2019). DOI: 10.17513/spno.28480.
26. Zaboronok A.A., Byvaltsev V.A., Kanygin V.V., Iarullina A.I., Kichigi nA.I., Taranin A.V., Volkova O.Yu., Mechetina L.V., Taskaev S.Yu., Muhamadiyarov R.A., Zavyalov E.L., Nakai K., Sato E., Yamamoto T., Mathis B.J., Matsumura A. Boron-neutron capture therapy in Russia: Preclinical evaluation of efficacy and perspectives of its application in neuro-oncology. New Armenian Medical Journal. 2017. Vol. 11. No. 1. P. 6-15.
27. Sauerwein W., Wittig A., Moss R., Nakagawa Y, eds. Neutron Capture Therapy. Principles and Applications. Berlin, Heidelberg: Springer, 2012. 553 p.
28. Skold K., H-Stenstam B., Diaz A.Z., Giusti V., Pellettieri L., Hopewell J.W. Boron Neutron Capture Therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f. Acta Neurol Scand. 2010. Vol. 122. No. 1. P. 58-62. DOI: 10.1111/j.1600-0404.2009.01267.x.
29. Iguchi Y., Michiue H., Kitamatsu M., Hayashi Y., Takenaka F., Nishiki T., Matsui H. Tumorspecific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model. Biomaterials. 2015. Vol. 56. P. 10-17. DOI: 10.1016/j.biomaterials.2015.03.061.
30. Barth R.F., Mi P., Yang W. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun (Lond). 2018. Vol. 38. No. 1. P. 35. DOI: 10.1186/s40880-018-0299-7.
31. Pan X., Wu G., Yang W., Barth R.F., Tjarks W., Lee R.J. Synthesis of cetuximab- immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR. Bioconjug Chem. 2007. Vol. 18. No. 1. P. 101-108. DOI: 10.1021/bc060174r.
32. Sibrian-Vazquez M., Vicente M.G.H. Boron tumor delivery for BNCT: Recent developments and perspectivesю In: Hosmane N.S., ed. Boron Science: New Technologies & Applications. CRC Press, 2011. P. 203-232.
33. Agarwal H.K., Khalil A., Ishita K., Yang W., Nakkula R.J., Wu L.C., Ali T., Tiwari R., Byun Y., Barth R.F., Tjarks W. Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer. Eur J Med Chem. 2015. Vol. 100. P. 197-209. DOI: 10.1016/j.ejmech.2015.05.042.
34. Stogniy M.Y., Zakharova M.V., Sivaev I.B., Godovikov I.A., Chizov A.r O., Bregadze V.I. Synthesis of new carborane-based amino acids. Polyhedron. 2013. Vol. 55. P. 117-120. DOI: 10.1016/j.poly.2013.02.076.
35. Gruzdev D.A., Levit G.L., Bazhov I.V., Demin A.M., Sadretdinova L.Sh., Ol'shevskaya V.A., Kalinin V.N., Krasnov V.P., Chupakhin O.N. Synthesis of novel carboranyl derivatives of a- amino acids. Russ Chem Bull. 2010. Vol. 59. No. 1. P. 110-111. DOI: 10.1007/s11172-010-0052-0.
36. Nakamura H. Liposomal boron delivery for neutron capture therapy. Methods Enzymol. 2009. Vol. 465 P. 179-208. DOI: 10.1016/S0076-6879(09)65010-2.
37. Kabalka G.W., Yao M.L., Marepally S.R., Chandra S. Biological evaluation of boronated unnatural amino acids as new boron carriers. Appl Radiat Isot. 2009. Vol. 67. No. 7-8 Suppl. P. S374-S379. DOI: 10.1016/j.apradiso.2009.03.104.
38. Chandra S., Ahmad T., Barth R.F., Kabalka G.W. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human spongioblastoma cells with imaging secondary ion mass spectrometry (SIMS). J. Microsc. 2014. Vol. 254. No. 3. P. 146-156. DOI: 10.1111/jmi.12126.
39. Michiue H., Sakurai Y., Kondo N., Kitamatsu M., Bin F., Nakajima K., Hirota Y., Kawabata S., Nishiki T., Ohmori I., Tomizawa K., Miyatake S., Ono K., Matsui H. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cellpenetrating peptide. Biomaterials. 2014. Vol. 35. No. 10. P. 3396-3405. DOI: 10.1016/j.biomaterials.2013.12.055.
40. Da Silva A.F., Seixas R.S., Silva A.M., Coimbra J., Fernandes A.C., Santos J.P., Matos A., Rino J., Santos I., Marques F. Synthesis, characterization and biological evaluation of carboranylmethylbenzo[b]acridones as novel agents for boron neutron capture therapy. Org Biomol Chem. 2014. Vol. 12. No. 28. P. 5201-5211. DOI: 10.1039/c4ob00644e.
41. Fan C.H., Wang T.W., Hsieh Y.K., Wang C.F, Gao Z., Kim A., Nagasaki Y., Yeh C.K. Enhancing boron uptake in brain glioma by a boron-polymer/microbubble complex with focused ultrasound. ACS Appl Mater Interfaces. 2019. Vol. 11. No. 12. P. 11144-11156. DOI: 10.1021/acsami.8b22468.
42. Alkins R.D., Brodersen P.M., Sodhi R.N., Hynynen K. Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound. Neuro Oncol. 2013. Vol. 15. No. 9. P. 1225-1235. DOI: 10.1093/neuonc/not052.
43. Geninatti-Crich S., Alberti D., Szabo I., Deagostino A., Toppino A., Barge A., Ballarini F., Bortolussi S., Bruschi P., Protti N., Stella S., Altieri S., Venturello P., Aime S. MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters. Chemistry. 2011. Vol. 17. No. 30. P. 8479-8486.